MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable sequencing, genotyping, microarray, and bioinformatics services. CD Genomics MicrobioSeq has launched the Bacterial Whole Genome De Novo Sequencing to help scientific researchers better understand bacterial biodiversity, physiology, metabolism and function.
Bacterial whole-genome sequencing can be divided into bacterial genome de novo sequencing and bacterial genome resequencing, which is a method to obtain the whole genome sequence of bacteria. MicrobioSeq can provide bacterial whole genome sequencing and bioinformatics analysis services to help you explore the genetic structure and function of microbial populations, evolutionary relationships, and the unique biological properties of strains.
CD Genomics provides next-generation sequencing and long-read sequencing technologies to sequence bacterial whole genome, utilizing the advanced Illumina HiSeq, Nanopore MinION, and PacBio SMRT platforms to produce high-quality sequencing data quickly and efficiently.
Using bacterial whole genome sequencing, a large number of single nucleotide polymorphisms (SNPs), insertions and deletions (InDels), and structural variations (SVs) can be discovered or identified. Bacterial whole genome sequencing can also be used to identify the unique biological characteristics (pathogenic mechanism, symbiotic mechanism, metabolic mechanism) of the strains and molecular strain typing. Bacterial whole genome sequencing is becoming more relevant to the medical sector, with applications such as diagnostics, epidemiology, risk management, and patient care.
“CD Genomics's automated and superior bacterial whole genome de novo sequencing platform allows us to sequence bacterial genomes de novo. We perform PacBio SMRT sequencing (100-150X), nanopore sequencing and/or Illumina HiSeq PE150 (100-200X) sequencing to assemble complete bacterial genomes. pacBio SMRT sequencing produces long read lengths, which are important for genome assembly, especially in GC-rich and repeat-dense regions. In contrast, illumina HiSeq sequencing is characterized by high throughput and accuracy. After QC, correction and filtering of the raw data, qualified reads are used to construct confidential sketches or complete genomes according to your needs,” commented the chief scientist of CD Genomics.
Bacterial whole genome de novo sequencing is the best method to obtain whole genome sequence maps of species without a reference genome. It allows bacterial identification, gene function analysis, variation studies, phylogenetic studies, and related disease studies. It has been widely used in many fields such as bacterial evolution, epidemiological studies, vaccine and drug development, and bacterial control.
About the MicrobioSeq Divison of CD Genomics
MicrobioSeq is the microbial genomics division of CD Genomics, which is a genomics service company with a good reputation for providing reliable microbial sampling products, microbial testing services, microbial genomics services, and integrated bioinformatics services.
Contact
Address: Shirley, NY 11967, USA
Email: contact@cd-genomics.com
